###begin article-title 0
###xml 78 96 78 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 78 96 <span type="species:ncbi:5691">Trypanosoma brucei</span>
The Non-Canonical CTD of RNAP-II Is Essential for Productive RNA Synthesis in Trypanosoma brucei
###end article-title 0
###begin p 1
Conceived and designed the experiments: AD VB. Performed the experiments: AD VB. Analyzed the data: AD VB. Contributed reagents/materials/analysis tools: AD. Wrote the paper: AD VB.
###end p 1
###begin p 2
###xml 509 527 507 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 643 652 627 636 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 143 148 <span type="species:ncbi:4932">yeast</span>
###xml 509 527 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 643 652 <span type="species:ncbi:5691">T. brucei</span>
The carboxy-terminal domain (CTD) of the largest subunit (RPB1) of RNA polymerase II (RNAP-II) is essential for gene expression in metazoa and yeast. The canonical CTD is characterized by heptapeptide repeats. Differential phosphorylation of canonical CTD orchestrates transcriptional and co-transcriptional maturation of mRNA and snRNA. Many organisms, including trypanosomes, lack a canonical CTD. In these organisms, the CTD is called a non-canonical CTD or pseudo-CTD (PsiCTD. In the African trypanosome, Trypanosoma brucei, the PsiCTD is approximately285 amino acids long, rich in serines and prolines, and phosphorylated. We report that T. brucei RNAP-II lacking the entire PsiCTD or containing only a 95-amino-acid-long PsiCTD failed to support cell viability. In contrast, RNAP-II with a 186-amino-acid-long PsiCTD maintained cellular growth. RNAP-II with PsiCTD truncations resulted in abortive initiation of transcription. These data establish that non-canonical CTDs play an important role in gene expression.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 174 177 162 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Cramer1">[1]</xref>
###xml 401 402 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 403 404 391 392 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 405 406 393 394 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 407 408 395 396 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 409 410 397 398 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 411 412 399 400 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sub>
###xml 413 414 401 402 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 416 419 404 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Allison1">[2]</xref>
###xml 421 424 409 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Corden1">[3]</xref>
###xml 441 444 429 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Egloff1">[4]</xref>
###xml 446 449 434 437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Buratowski1">[5]</xref>
###xml 698 701 686 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Phatnani1">[6]</xref>
###xml 702 705 690 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Sims1">[8]</xref>
###xml 860 863 848 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Buratowski1">[5]</xref>
###xml 865 868 853 856 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Meinhart1">[9]</xref>
###xml 1010 1014 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Stiller1">[10]</xref>
###xml 1016 1020 1002 1006 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Dacks1">[11]</xref>
###xml 1066 1087 1052 1073 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trichomonas vaginalis</italic>
###xml 1121 1143 1107 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bonnemaisonia hamifera</italic>
###xml 1275 1279 1259 1263 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Schumacher1">[12]</xref>
###xml 1281 1285 1265 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Guo1">[13]</xref>
###xml 322 327 <span type="species:ncbi:4932">yeast</span>
###xml 1066 1087 <span type="species:ncbi:5722">Trichomonas vaginalis</span>
###xml 1121 1143 <span type="species:ncbi:31369">Bonnemaisonia hamifera</span>
RNA polymerase II (RNAP-II) is the eukaryotic enzyme responsible for synthesis of mRNA. This enzyme is an approximately550 kDa complex consisting of twelve subunits, RPB1-12 [1]. The carboxy-terminal domain (CTD) of the largest subunit, RPB1, is essential for cell survival. In well-studied organisms, such as metazoa and yeast, the CTD consists of consensus heptapeptide repeats having the sequence Y1S2P3T4S5P6S7 ([2], [3] and reviewed in [4], [5]). The CTD plays a pivotal role in RNA production by recruiting multiple proteins that modulate transcription initiation, transcription elongation, transcription termination, co-transcriptional mRNA 5' capping, RNA splicing, and RNA polyadenylation [6]-[8]. Interaction of proteins with the CTD is orchestrated by dynamic and differential phosphorylation. The patterns of phosphorylation make up the "CTD code" [5], [9]. Non-canonical CTDs, which lack the heptapeptide repeats and thus are pseudo CTDs (PsiCTDs), exist in a wide variety of eukaryotic organisms [10], [11]. For example, the early branching protozoan, Trichomonas vaginalis, and the multicellular red alga, Bonnemaisonia hamifera, as well as members of the Apicomplexian, Stylonichia, and Kinetoplastid groups contain PsiCTDs as part of their RNAP-II machinery [12], [13]. We sought to determine whether a PsiCTD is essential for gene expression.
###end p 4
###begin p 5
###xml 205 209 191 195 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Gilinger1">[14]</xref>
###xml 210 214 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Yurchenko1">[17]</xref>
###xml 244 262 230 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 362 370 334 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g001">Figure 1</xref>
###xml 375 379 347 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Smith1">[15]</xref>
###xml 381 385 353 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Grondal1">[16]</xref>
###xml 391 400 363 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 766 775 738 747 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 900 904 872 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Patrick1">[18]</xref>
###xml 923 932 895 904 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 1081 1097 1053 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leishmania major</italic>
###xml 1168 1172 1140 1144 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Thomas1">[19]</xref>
###xml 244 262 <span type="species:ncbi:5691">Trypanosoma brucei</span>
###xml 391 400 <span type="species:ncbi:5691">T. brucei</span>
###xml 766 775 <span type="species:ncbi:5691">T. brucei</span>
###xml 791 796 <span type="species:ncbi:4932">yeast</span>
###xml 923 932 <span type="species:ncbi:5691">T. brucei</span>
###xml 1081 1097 <span type="species:ncbi:5664">Leishmania major</span>
Among the Kinetoplastids, the largest subunit of RNAP-II has an approximately300 amino acid-long PsiCTD that lacks heptapeptide repeats and exhibits little amino acid similarity to CTDs of other organisms [14]-[17]. In the African trypanosome, Trypanosoma brucei, the PsiCTD of RNAP-II is an approximately285 amino acid-long carboxyl terminal extension of RPB1 (Figure 1 and [15], [16]). In T. brucei, RNAP-II synthesizes two very different types of RNA, a long polycistronic precursor mRNA (pre-mRNA) and a short, capped Spliced Leader (SL) RNA. mRNA maturation require addition of SL RNA to pre-mRNAs through a trans-splicing reaction. Different forms of RNAP-II, associated with specific transcription factors, likely transcribe SL RNAs and pre-mRNAs. Indeed the T. brucei homolog of the yeast transcription factor Spt16 appears to associate with protein-coding genes but not with the SL RNA gene [18]. In contrast, the T. brucei homolog of the mammalian snRNA transcription factor SNAPc appears to associate only with the SL RNA gene promoter, although one subunit of SNAPc in Leishmania major, a relate parasite, occupies regions upstream of protein-coding genes [19]. Whether RNAP-II PsiCTD is important for transcription of either the SL RNA gene and/or protein-coding genes is unknown.
###end p 5
###begin title 6
###xml 14 23 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 14 23 <span type="species:ncbi:5691">T. brucei</span>
The PsiCTD of T. brucei RNAP-II lacks conserved heptapeptide sequence motifs found in most other eukaryotes.
###end title 6
###begin p 7
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 161 170 161 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 891 900 855 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 24 33 <span type="species:ncbi:5691">T. brucei</span>
###xml 161 170 <span type="species:ncbi:5691">T. brucei</span>
###xml 843 848 <span type="species:ncbi:9606">human</span>
###xml 853 858 <span type="species:ncbi:4932">yeast</span>
###xml 891 900 <span type="species:ncbi:5691">T. brucei</span>
(A) Domain structure of T. brucei RPB1 showing the presence of the characteristic A-H domains and the divergent carboxy-terminal domain. The carboxy terminus of T. brucei RPB1 lacks the highly conserved YSPTSPS repeats that orchestrate multiple co-transcriptional processes in the well-studied eukarya. Four different RPB1 proteins analyzed in this study are diagrammed: RPB1 containing no PsiCTD (DeltaPsiCTD, truncated at amino acid 1481), one-third of PsiCTD (1/3 PsiCTD, truncated at amino acid 1576), two-thirds of PsiCTD (2/3 PsiCTD, truncated at amino acid 1667), and full length PsiCTD (full PsiCTD). The heavy line at the C-terminus of each truncation represents the five conserved amino acids (E/DEEEQ). The location of the approximately27 kDa Lys-C fragment is indicated with a horizontal line over the PsiCTD. (B) Alignment of the human and yeast CTD with the PsiCTD sequence of T. brucei RPB1. A portion of the H domain is included (gray bar) as reference. The CTD's linker region (thin line) and the heptapeptide repeat domain (thick line) are shown. Thirty-one of the 52 heptapeptide repeats in the mammalian CTD are shown. The PsiCTD truncations are defined by arrows following the final amino acid contained in each mutant protein. Grey boxes show similar amino acids in two sequences, black boxes show similar amino acids in all three sequences.
###end p 7
###begin p 8
###xml 101 110 101 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 179 186 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 101 110 <span type="species:ncbi:5691">T. brucei</span>
To address if non-canonical CTDs play a fundamental role in gene expression, we undertook a study of T. brucei RNAP-II PsiCTD. We altered RNAP-II and tested its function using an in vivo assay system and discovered that the PsiCTD is essential for cell survivial and production of both SL RNA and mRNA. Nascent transcription analysis demonstrated that the PsiCTD is required specifically for productive transcription initiation, as an RNAP-II severely truncated within the PsiCTD caused abortive initiation. These results demonstrate that a non-canonical CTD is a vital component of the RNAP-II machinery in eukaryotic cells.
###end p 8
###begin title 9
Results
###end title 9
###begin title 10
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 0 9 <span type="species:ncbi:5691">T. brucei</span>
T. brucei PsiCTD undergoes phosphorylation
###end title 10
###begin p 11
###xml 34 43 34 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 144 148 144 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Chapman1">[20]</xref>
###xml 261 263 259 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 319 328 317 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 484 486 482 484 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 804 813 802 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g002">Figure 2A</xref>
###xml 922 931 920 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g002">Figure 2B</xref>
###xml 1027 1031 1025 1029 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Das1">[21]</xref>
###xml 1100 1102 1096 1098 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1419 1428 1401 1410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g001">Figure 1A</xref>
###xml 1588 1597 1556 1565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g002">Figure 2C</xref>
###xml 1630 1632 1598 1600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 1675 1684 1643 1652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g002">Figure 2D</xref>
###xml 1866 1875 1820 1829 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g002">Figure 2C</xref>
###xml 2063 2072 2015 2024 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 34 43 <span type="species:ncbi:5691">T. brucei</span>
###xml 319 328 <span type="species:ncbi:5691">T. brucei</span>
###xml 2063 2072 <span type="species:ncbi:5691">T. brucei</span>
It has been shown previously that T. brucei RNAP-II is modified by phosphorylation, despite the lack of consensus heptapeptide repeat sequences [20]. To determine whether the phosphorylation occurs within the PsiCTD, we directly visualized RNAP-II labeled with 32P-orthophosphate. For this work, we tagged RNAP-II in a T. brucei procyclic cell line by stably-expressing the RPB3 subunit of the enzyme with a tandem affinity tag. These transgenic cells were metabolically labeled with 32P-orthophosphate and RNAP-II was purified from nuclear extracts using protein A and streptavidin-binding peptide affinity chromatography. An autoradiograph of the purified protein, separated into polypeptides by denaturing gel electrophoresis, indicated that the largest subunit (RPB1) is modified by phosphorylation (Figure 2A). A stained gel of the purified proteins revealed both phosphorylated and non-phosphorylated forms of RPB1 (Figure 2B). Seven of the eleven other RNAP-II subunits, as verified by mass spectrometry, were also seen [21]. To determine whether phosphorylation occurs in the PsiCTD of RPB1, 32P-labeled RPB1 was subjected to in-gel proteolysis by endoproteinase Lys-C, which cleaves the peptide bond at the carboxy side of lysine. Lys-C digestion of RPB1 generated a 253 amino acid long, approximately27 kDa, peptide consisting only of the PsiCTD (from amino acid 1491-1744) minus its terminal 21 amino acids (Figure 1A). The remainder of RPB1 was fragmented into <76 amino acid-long peptides. Immunoblotting with anti-PsiCTD antibodies detected the approximately27 kDa peptide (Figure 2C). Lys-C digestion products from 32P-orthophosphate-labeled RPB1 are shown in Figure 2D. The heterogeneous collection of radiolabeled peptides migrating more slowly than approximately27 kDa are PsiCTD peptides that differ in phosphorylation patterns. The immunoblot in Figure 2C shows most clearly the non-phosphorylated PsiCTD because the phosphorylated peptides migrate as a broad band that eludes antibody detection. Thus, our analysis demonstrates that although T. brucei RNAP-II PsiCTD lacks a heptapeptide repeat sequence, it undergoes phosphorylation.
###end p 11
###begin title 12
###xml 14 23 12 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 14 23 <span type="species:ncbi:5691">T. brucei</span>
The PsiCTD of T. brucei RNAP-II undergoes phosphorylation.
###end title 12
###begin p 13
###xml 87 89 87 89 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 157 159 157 159 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 183 184 183 184 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Das1">[21]</xref>
###xml 1086 1087 1066 1067 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1114 1115 1092 1093 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1287 1288 1265 1266 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
(A) RNAP-II tandem affinity purified from RPB3-tagged cells metabolically labeled with 32P-orthophosphate was separated on SDS-8% PAGE and autoradiographed. 32P-labeled RPB1 (RPB1-*PO4) is shown (right lane). The left lane contains a similar purification from A7-tagged cells and served as a control for protein purification[21]. (B) Eight of the twelve subunits of RNAP-II are shown on silver-stained SDS-8% PAGE. The two RPB1 bands were confirmed as the phosphorylated and non-phosphorylated forms of RPB1 (II0 and IIA) by the conversion of II0 to IIA after lambda protein phosphatase treatment. II0 and IIA were detected using anti-PsiCTD antibody (Daniels J-P, Wickstead, W and Gull, K, personal communication). Asterisks mark four yet to be identified polypeptides. (C) A Western blot using anti-PsiCTD antibodies identified the approximately27 kDa as in-gel digestion product of RPB1 with endoproteinase Lys-C. The input (left lane) was RPB1 prior to proteolysis. (D) An autoradiograph that contains the PsiCTD (PsiCTD -*PO4, right lane), generated by in-gel digestion of RPB1-*PO4 with Lys-C. The PsiCTD-*PO4 migrates more slowly than the unmodified peptide and is broad band probably because it contains a heterogeneous number of modifications. The input (left lane) was RPB1-*PO4 prior to proteolysis.
###end p 13
###begin title 14
RNAi-targeting of mRNA 3'UTR allows regulated depletion of RPB1
###end title 14
###begin p 15
###xml 757 766 755 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 862 871 860 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g003">Figure 3A</xref>
###xml 961 970 959 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g003">Figure 3B</xref>
###xml 757 766 <span type="species:ncbi:5691">T. brucei</span>
To test directly the importance of RNAP-II PsiCTD in transcription, we used RNAi to deplete endogenous RNAP-II (referred to as 'endo') and replace it with mutant RNAP-II, conditionally expressed from an exogenously provided DNA cassette. Endo RNAP-II relies upon RPB1 that is encoded by two sets of allelic gene copies on chromosomes 4 and 8. These genes differ slightly in their protein-coding regions. Fortunately, RPB1 mRNAs generated from all four alleles contain identical 3'UTRs, as determined by analysis of RPB1 mRNA by 3' RACE-PCR (data not shown). We generated cell lines containing inducible RNAi that targeted the RPB1 3'UTR. As expected, targeting 3'UTR of RPB1 mRNA by tetracycline-inducible RNAi expression stops cellular growth of procyclic T. brucei by day 2, in contrast to uninduced cells. The induced cells progressed to cell death by day 4 (Figure 3A). Western analysis of total cellular protein showed decrease in RPB1 beginning by day 1 (Figure 3B).
###end p 15
###begin title 16
Depletion of RPB1 by RNAi causes lethality.
###end title 16
###begin p 17
###xml 311 320 309 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 311 320 <span type="species:ncbi:5691">T. brucei</span>
(A) Growth curves of a clonal transgenic RNAi-containing cell line in the presence (black squares) and absence (gray squares) of tetracycline. Tetracycline was added on day 0. (B) Western analysis of whole cell lysates prepared on days 0-4 after RNAi induction, using anti-PsiCTD antibodies, shows depletion of T. brucei RPB1. Loading controls are in the lower panel.
###end p 17
###begin title 18
RNAP-II containing 1/3 PsiCTD is toxic and causes cell death
###end title 18
###begin p 19
###xml 164 173 158 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g001">Figure 1A</xref>
###xml 551 560 525 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006959.s001">Figure S1</xref>
To study whether RPB1 mutant proteins can support transcription, we expressed tagged versions of full, 2/3, 1/3 and null (Delta) PsiCTD domain-containing proteins (Figure 1A). The full PsiCTD or 2/3 PsiCTD RPB1 transgenic cell lines were readily established. However, cell lines with a 1/3 PsiCTD or Delta PsiCTD RPB1 were difficult to establish: only one cell line for each construct was obtained after multiple transfections. The 1/3 PsiCTD or Delta PsiCTD RPB1-containing parasites grew poorly and had low levels of non-phosphorylated tagged-RPB1 (Figure S1). These results indicated that expression of either the 1/3 PsiCTD or Delta PsiCTD poison cells and prohibit selection of robustly expressing cell lines.
###end p 19
###begin p 20
###xml 126 133 124 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0006959-t001">Table 1</xref>
###xml 231 240 227 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0006959.s001">Figure S1</xref>
###xml 422 431 410 419 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g004">Figure 4A</xref>
###xml 845 854 825 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g004">Figure 4A</xref>
To investigate whether 1/3 PsiCTD poisons the RNAP-II enzyme, we tailored RPB1 transgenes to express in an inducible fashion (Table 1). The discovery that RNAP-II with 2/3 PsiCTD was well tolerated and modified by phosphorylation (Figure S1), whereas 1/3 PsiCTD was not, prompted us to compare 2/3 PsiCTD with 1/3 PsiCTD RNAP-II in our studies. Induced expression of 2/3 PsiCTD RNAP-II resulted in normal cellular growth (Figure 4A). However, induced expression of 1/3 PsiCTD RNAP-II was toxic to cells. The crippling effect of 1/3 PsiCTD RNAP-II was evident in the rapid growth arrest and loss of viable cells. Microscopic observation following expression of 1/3 PsiCTD RNAP-II revealed striking changes: cells became rounded and formed large aggregates. In contrast, cell morphology was normal following expression of RNAP-II with 2/3 PsiCTD (Figure 4A).
###end p 20
###begin title 21
RNAP-II with a 1/3 PsiCTD poisons cell growth.
###end title 21
###begin p 22
###xml 32 41 32 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 480 489 476 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 648 657 644 653 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 32 41 <span type="species:ncbi:5691">T. brucei</span>
###xml 480 489 <span type="species:ncbi:5691">T. brucei</span>
###xml 648 657 <span type="species:ncbi:5691">T. brucei</span>
(A) Growth curves of transgenic T. brucei cell lines in the presence (black, on) or absence (gray, off) of either 2/3 PsiCTD (left panel, square) or 1/3 PsiCTD RPB1 (right panel, circle). Western analyses of whole cell lysates before (off) and two days after (on) induction of exogenous RPB1 are shown. Microscopic images of cellular morphology two days post-induction of exogenous proteins are shown. (B) Western analyses of 10 to 30% sucrose gradient fractions. Both endogenous T. brucei RPB1 (top panel, endo) and exogenous RPB1 (bottom panel, tagged) are shown. (C) Immunoblot analysis of whole cell extract (left three lanes, Extract) or anti-T. brucei RPB4 immune-captured proteins (right three lanes, alpha-RPB4) from wild-type (WT) and transgenic parasites expressing exogenous 2/3 PsiCTD or 1/3 PsiCTD RPB1.
###end p 22
###begin title 23
RPB1 expression schemes for PsiCTD analysis.
###end title 23
###begin p 24
###xml 96 105 94 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g004">Figure 4B</xref>
###xml 708 717 698 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g004">Figure 4C</xref>
To verify that the 1/3 PsiCTD RPB1 was incorporated into RNAP-II, we analyzed enzyme complexes (Figure 4B). Fractionation of nuclear extract by sucrose density-gradient centrifugation confirmed that tagged-2/3 PsiCTD and tagged-1/3 PsiCTD RPB1 assembled into complexes that migrated near the bottom of the gradient. These same fractions were enriched for endogenous RNAP-II. Transcriptionally active endogenous RNAP-II also migrated at this position in similar sedimentation velocity measurements (data not shown). Western blot analysis of immunoprecipitated proteins captured by polyclonal anti-RPB4 antibody demonstrated the presence of tagged-1/3 PsiCTD, tagged-2/3 PsiCTD, or endogenous RPB1 in RNAP-II (Figure 4C). These results confirmed that 2/3 PsiCTD or 1/3 PsiCTD RPB1 were incorporated into RNAP-II. Thus, RNAP-II with 1/3 PsiCTD is toxic to cells and produces a dominant negative effect over endogenous RNAP-II.
###end p 24
###begin title 25
RNAP-II containing 2/3 PsiCTD rescues cellular growth in absence of endogenous PsiCTD
###end title 25
###begin p 26
###xml 368 376 358 366 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g005">Figure 5</xref>
###xml 814 823 798 807 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g005">Figure 5A</xref>
Although a 1/3 PsiCTD RNAP-II had a dominant-negative effect, cells expressing both full-length PsiCTD and 2/3 PsiCTD RNAP-II grew normally. We speculated that RNAP-II harboring a 2/3 PsiCTD might be as proficient as the endogenous enzyme in supporting cell growth. Thus, a 2/3 PsiCTD RNAP-II was tested for its ability to rescue cells depleted of endogenous RNAP-II (Figure 5). We established stable cell lines containing a regulated RNAi construct and a regulated tagged-RPB1 gene. Addition of tetracycline induced RNAi production and tagged RPB1 expression. Thus, endogenous RPB1 was selectively destroyed and the tagged-RPB1 proteins that contain either the 2/3 PsiCTD or 1/3 PsiCTD were produced. Growth curves showed that 2/3 PsiCTD RNAP-II sustained cellular growth after RNAi-depletion of endogenous RPB1 (Figure 5A). In contrast, 1/3 PsiCTD RNAP-II failed to rescue the cells.
###end p 26
###begin title 27
RNAP-II with a 2/3 PsiCTD supports cell growth, whereas enzyme with a 1/3 PsiCTD does not.
###end title 27
###begin p 28
###xml 21 30 21 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 478 486 474 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g004">Figure 4</xref>
###xml 21 30 <span type="species:ncbi:5691">T. brucei</span>
(A) Growth curves of T. brucei RNAi cell lines in the presence (black squares and circles) or absence of tetracycline (gray squares and circles). Tetracycline causes RNAi-dependent knock down of endogenous RPB1 and induction of exogenous RPB1. 2/3 PsiCTD RPB1 is in the left panel, 1/3 PsiCTD RPB1 is in the right panel. (B) Immunoblot of whole cell lysates from cultures shown in (A) after tetracycline induction for 0-3 days. Endogenous and exogenous RPB1 were detected as in Figure 4. The four bands in the left upper portion are the phosphorylated and non-phosphorylated forms of the endogenous and 2/3 PsiCTD RBP1 proteins. The upper right panel displays three bands as the 1/3 PsiCTD RPB1 is not phosphorylated.
###end p 28
###begin p 29
###xml 107 116 105 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g005">Figure 5B</xref>
###xml 406 415 402 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g005">Figure 5B</xref>
###xml 618 627 612 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g005">Figure 5B</xref>
Endogenous RPB1 depletion was monitored by immunoblotting with anti-PsiCTD antibody. The top, left blot in Figure 5B shows that both phosphorylated and non-phosphorylated forms of the endogenous RPB1 decreased after RNAi-targeting. In addition, both phosphorylated and non-phosphorylated forms of the tagged-2/3 PsiCTD RPB1 were present after induction. Similar results are shown in the top, right blot in Figure 5B, although the diminished number of epitopes on the 1/3 PsiCTD resulted in weak antibody detection. Expression of tagged proteins was independently monitored in immunoblots by using anti-tag antibodies (Figure 5B, lower blots). As noted above, the 1/3 PsiCTD RPB1 failed to undergo phosphorylation, and thus a single band corresponding to the tagged protein was observed. These data confirmed that induced expression of tagged 2/3 and 1/3 PsiCTD RPB1 occurred in our experiments. Taken together, these results argue that PsiCTD contributes to cell viability, likely as an essential component of functional RNAP-II.
###end p 29
###begin title 30
RNAP-II requires a 2/3 PsiCTD to maintain steady-state transcript levels
###end title 30
###begin p 31
###xml 405 414 399 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g006">Figure 6A</xref>
To determine the role of PsiCTD on RNAP-II transcription, first we analyzed transgenic cells for steady-state transcript levels following concomitant endogenous RPB1 depletion and tagged-RPB1 induction. Northern blot analyses of total RNA confirmed that expression of the tagged-RPB1 mRNA from transgenes containing either the 2/3 PsiCTD or 1/3 PsiCTD was tightly regulated and induced with tetracycline (Figure 6A). These data are shown schematically in the right portion of the panel. Levels of 7SL RNA, which requires RNAP-III, were unaffected during the two-day course of the experiment. In contrast, levels of beta-tubulin mRNA, which requires RNAP-II for synthesis, were markedly reduced in cells expressing the 1/3 PsiCTD RNAP-II; only approximately40% of the beta-tubulin mRNA remained by day 2 after induction. In cells containing 2/3 PsiCTD RNAP-II, no decrease in beta-tubulin mRNA was observed. The differential effect on beta-tubulin levels supported the observation that while RNAP-II with 1/3 PsiCTD was crippled, RNAP-II with 2/3 PsiCTD was functional. Finally, levels of procyclin/EP1 mRNA, which requires RNAP-I, indicated that approximately60% of the procyclin/EP1 mRNA was present in 1/3 PsiCTD-expressing cells in comparisons to cells expressing endogenous enzyme. The decrease in EP1 mRNA steady-state levels was likely due to inefficient mRNA maturation, which requires the RNAP-II-dependent SL RNA transcript.
###end p 31
###begin title 32
RNAP-II requires a 2/3 PsiCTD to maintain steady-state levels of SL RNA and mRNA.
###end title 32
###begin p 33
###xml 84 93 84 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 193 202 193 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 84 93 <span type="species:ncbi:5691">T. brucei</span>
###xml 193 202 <span type="species:ncbi:5691">T. brucei</span>
(A) Northern blot analysis of total RNA prepared from wild-type (WT) and transgenic T. brucei cell lines before (day 0) and after 1 and 2 days following RNAi-dependent knock down of endogenous T. brucei RPB1 and induction of exogenous 2/3 PsiCTD or 1/3 PsiCTD RPB1. Ribosomal RNAs (rRNAs) were visualized by ethidium bromide staining. Transgene-derived RPB1 mRNA, beta-tubulin mRNA, EP1 mRNA, and 7SL RNA were visualized by hybridizing with specific radiolabelled oligonucleotides. beta-tubulin and EP1 mRNA levels were normalized using 7SL RNA and considered 100% on day 0. Transgene-derived RPB1 mRNA is indicated as 100% on day 1. (B) SL RNA was analyzed by primer extension of RNA from cells expressing RPB1 as in (A). Radiolabelled oligonucleotides hybridized to either SL RNA or U2 snRNA in the primer extension. A line graph shows percent SL RNA with respect to U2 snRNA after two days of tetracycline induction. Day 0 is considered 100%. A representative experiment from three independent experiments is shown.
###end p 33
###begin p 34
###xml 81 90 81 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g006">Figure 6B</xref>
To test this prediction, we assessed SL RNA levels by primer extension analysis (Figure 6B). Cells that relied on 1/3 PsiCTD RNAP-II exhibited a striking decrease in SL RNA steady-state levels; there was a 70% decrease on day 1 and a 85% decrease by day 2. In contrast, cells containing 2/3 PsiCTD RNAP-II maintained SL RNA levels. They experienced only a approximately30% decrease on day 1 that did not change by day 2. Thus, 1/3 PsiCTD RNAP-II was probably incapable of making new SL RNA transcripts and thus failed to maintain a reservoir of SL RNA necessary for efficient mRNA maturation.
###end p 34
###begin title 35
RNAP-II with 1/3 PsiCTD is defective in transcription and causes abortive initiation
###end title 35
###begin p 36
###xml 289 298 280 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g007">Figure 7A</xref>
To examine how the 1/3 PsiCTD impairs RNAP-II function, we assessed nascent RNA synthesis in transgenic cells before and after expression of 1/3 PsiCTD RPB1-containing enzyme. In comparison to uninduced cells, cells utilizing 1/3 PsiCTD RNAP-II poorly synthesized beta-tubulin and SL RNA (Figure 7A). Reduced synthesis of beta-tubulin and SL RNA was also observed in cells utilizing 2/3 PsiCTD-containing RNAP-II, although this reduction was minimal. For the cells relying on the 1/3 PsiCTD RNAP-II, we observed an overall decrease in RNAP-I (procyclin/EP1 and 18S rRNA) and RNAP-III (7SL RNA and 5S rRNA) transcription, which probably indicates a general reduction in their transcriptional capacity.
###end p 36
###begin title 37
RNAP-II with 1/3 PsiCTD is impaired in synthesizing SL RNA and pre-mRNA and produced abortive initiation.
###end title 37
###begin p 38
###xml 55 63 55 63 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g006">Figure 6</xref>
###xml 831 840 828 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 1041 1046 1038 1041 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n&#8804;4</sub>
###xml 1814 1816 1805 1807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 831 840 <span type="species:ncbi:5691">T. brucei</span>
(A) Analysis of nascent RNA prepared from cells, as in Figure 6, before (day 0) and 2 days after tetracycline induction. PCR-generated DNAs for the indicated genes were immobilized on nylon membrane and hybridized with radiolabelled nascent RNA prepared from permeabilized cells. A line diagram indicates the changes in nascent RNA, as measured by densitometric analysis of slots from two independent experiments, and normalized to the pUC19 hybridization signal. * marks RNAP-II-transcribed SL RNA (black square), beta-tubulin (gray square) and the SL RNA downstream region (open square). RNAP-I-transcribed EP1 (black circle), 18S rRNA (open circle), and RNAP-III-transcribed 7SL RNA (open triangle) and 5S rRNA (black triangle), are also shown. Day 0 is indicated as 100%. (B) Nascent SL RNA, from wild-type (WT) and transgenic T. brucei cells before (day 0) and after 1 and 2 days of exogenous RPB1 expression as in (A) were analyzed by denaturing 8% PAGE. Labeled SL RNA and tRNA are shown. Increasing amounts of short transcripts, (rN)n</=4, are produced in permeabilized cells expressing the 1/3 PsiCTD RNAP-II. The short transcripts are evident in the brief exposure. Nascent SL RNA levels with respect to tRNA levels are indicated on the left y-axis. Day 0 is indicated as 100%. The increase in short transcripts before (day 0) and after 1 and 2 days after RPB1 expression is shown on the right y-axis. Fold increase was always compared to the wild-type level. Markers are shown in the leftmost lane of the gel. (C) Analysis of the short transcripts produced in permeabilized cells expressing 1/3 PsiCTD RNAP-II on day 2 of tetracycline induction. Radiolabelled mononucleotides were produced by alkali hydrolysis of the gel-purified short transcripts, identifying them as RNA. Markers (lanes 1 and 2) and 32P-UTP (lane 3) are shown on the gel. (D) The short transcripts, when treated with TAP followed by RNA ligase, formed larger RNAs by self-ligation (lanes 4 and 7). Larger RNAs were not detected in the absence of TAP enzyme (lanes 3 and 6), indicating the presence of a tri-phosphate group at the 5' end of the short transcripts. Lanes 2 and 5 contain the input (eluted) RNA. Marker is shown in lane 1.
###end p 38
###begin p 39
###xml 194 203 190 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g007">Figure 7B</xref>
###xml 553 562 533 542 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g007">Figure 7B</xref>
We verified that the 1/3 PsiCTD RNAP-II is less efficient in transcription than its wild-type or 2/3 PsiCTD-containing homolog by direct visualization of newly synthesized, radiolabeled SL RNA (Figure 7B). Nascent SL RNA was significantly more reduced in cells containing 1/3 PsiCTD RNAP-II compared to cells containing 2/3 PsiCTD RNAP-II (approximately60% compared to 20%), after two days of expression. Interestingly, we also observed an increase in small radiolabeled molecules migrating near the bottom of the gel, as shown in the brief exposure in Figure 7B. Compared to wild-type, cells expressing either 2/3 PsiCTD RNAP-II or 1/3 PsiCTD RNAP-II produced increased level of very short (approximately4 nt long) transcripts. The amount of short transcripts was greater in cells containing 1/3 PsiCTD RNAP-II (eight-fold over wild-type) than in cells containing 2/3 PsiCTD (four-fold over wild-type). We postulate that these RNAs were generated from abortive initiation.
###end p 39
###begin p 40
###xml 103 112 103 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g007">Figure 7C</xref>
###xml 187 196 187 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g007">Figure 7B</xref>
###xml 447 456 447 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g007">Figure 7D</xref>
###xml 365 372 <span type="species:ncbi:4097">Tobacco</span>
We first determined that the radiolabelled molecules were RNA, and thus sensitive to alkali treatment (Figure 7C). Mononucleotides were produced from gel-purified, short transcripts (see Figure 7B, brief exposure). To confirm that the short RNAs indeed originated from transcription initiation events, we characterized their 5' end. Short transcripts, treated with Tobacco Acid Pyrophosphatase (TAP), were ligated to form a ladder of longer RNAs (Figure 7D). No ligation products were observed when TAP-treatment was omitted. Taken together, the nascent transcription experiments supported the conclusion that RNAP-II requires a PsiCTD to enter into a productive transcription process.
###end p 40
###begin title 41
Discussion
###end title 41
###begin p 42
###xml 138 147 138 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 138 147 <span type="species:ncbi:5691">T. brucei</span>
The present work describes the first characterization of an RNAP-II non-canonical CTD, which is found in many single- cell organisms. The T. brucei RNAP-II uses a non-canonical CTD for cell growth and viability. The growth defect associated with PsiCTD deletions was likely a direct result of decreased mRNA production. Specifically, when the PsiCTD is truncated, defective RNAP-II produced less mRNA and SL RNA and increased abortive initiation products.
###end p 42
###begin p 43
###xml 191 212 191 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trichomonas vaginalis</italic>
###xml 256 267 256 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trichomonas</italic>
###xml 358 362 358 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Schumacher1">[12]</xref>
###xml 402 411 402 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 488 492 488 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Das1">[21]</xref>
###xml 494 498 494 498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Devaux1">[22]</xref>
###xml 740 748 736 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g001">Figure 1</xref>
###xml 854 863 848 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g005">Figures 5</xref>
###xml 868 869 862 863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g006">6</xref>
###xml 191 212 <span type="species:ncbi:5722">Trichomonas vaginalis</span>
###xml 402 411 <span type="species:ncbi:5691">T. brucei</span>
A consequence of a non-canonical CTD is the opportunity for RNAP-II to partner with unknown proteins. This contention is best illuminated by the elegant biochemical and structural studies in Trichomonas vaginalis. Here, a non-canonical CTD partners with a Trichomonas-specific protein, IBP39, to stably assemble RNAP-II at the initiator element of promoters [12]. Affinity-purification of RNAP-II from T. brucei revealed several copurified proteins that appear to be trypanosome-specific [21], [22]. We speculate that some of these proteins participate in gene expression through specific interaction with PsiCTD. Indeed, a ten amino acid motif (SSYHLQ-SVAP) is shared among trypanosomes within the serine/proline-rich subdomain of PsiCTD (Figure 1). This motif is within the 2/3 PsiCTD truncation that rescued cells when wild-type RNAP-II was depleted (Figures 5 and 6). In summary, these observations are consistent with non-canonical CTD having significant roles in organism-specific RNAP-II machineries.
###end p 43
###begin p 44
###xml 184 185 184 185 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sub>
###xml 266 267 266 267 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Phatnani1">[6]</xref>
###xml 346 354 346 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T.brucei</italic>
###xml 412 420 410 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g002">Figure 2</xref>
###xml 760 769 736 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 1011 1012 985 986 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sub>
###xml 1126 1129 1100 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Egloff1">[4]</xref>
###xml 346 354 <span type="species:ncbi:5691">T.brucei</span>
###xml 760 769 <span type="species:ncbi:5691">T. brucei</span>
Modification of canonical CTD by phosphorylation at specific serine residues is required for orchestrating transcriptional activities in better studied eukaryotes. It is known that a S5 phospho CTD-code dictates that an enzyme leaves a preinitiation complex, and a S2 phospho CTD-code dictates that an enzyme becomes elongation competent [6]. In T.brucei, we found phosphorylated forms of PsiCTD within RNAP-II (Figure 2). Proteolytic digestion of phospho-PsiCTD produced what was most likely a heterogeneous set of differentially phosphorylated PsiCTDs. We note that there are approximately30 potential phosphorylation sites within the 2/3 PsiCTD that are absent from the 1/3 PsiCTD. Thus, we speculate that a phosphorylation-code occurs within the PsiCTD in T. brucei that may account for the two different RNAP-II-dependent reactions, namely, transcription of short, capped SL RNAs and long pre-mRNAs. Such a PsiCTD code may allow RNAP-II to specifically function at the SL RNA gene promoter, much like the S7 phosphorylation mark on the mammalian CTD directs polymerase specifically during small nuclear RNA transcription [4].
###end p 44
###begin p 45
###xml 213 217 213 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Chapman2">[23]</xref>
###xml 389 397 387 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g001">Figure 1</xref>
The structure of the canonical CTD is divided into three subdomains: the linker region, the central reiterated region that harbors intact and degenerate heptapeptide repeats, and the terminal short acidic peptide [23]. The PsiCTD parallels the CTD in structure; it contains a linker region of size similar to CTD, a central serine/proline-rich region, and a terminal short acidic peptide (Figure 1). In the case of 1/3 PsiCTD, the RNAP-II contained a PsiCTD having only the linker region plus a small part of the central serine/proline-rich region. This enzyme failed to rescue cell growth when wild-type RNAP-II was depleted. In addition, we did not observe phosphorylation of the 1/3 PsiCTD. In contrast, 2/3 PsiCTD of RNAP-II contained the linker region plus half of the central serine/proline-rich region. This enzyme was phosphorylated within the PsiCTD and allowed cell growth in the absence of wild-type RNAP-II. Taken together, it appears that the central serine/proline-rich region of the PsiCTD is important for polymerase function.
###end p 45
###begin p 46
###xml 360 378 356 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g007">Figure 7B, C and D</xref>
###xml 540 544 536 540 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Chapman3">[24]</xref>
Although 2/3 PsiCTD could sustain cell growth, it generated increased levels of abortive transcripts. Nascent transcription in cells containing the 1/3 PsiCTD generated even higher levels of abortive transcripts. These transcripts were confirmed to be abortively initiated RNA, as they possessed 5' tri-phosphate ends, a signature of transcription initiation (Figure 7B, C and D). Studies of the mammalian CTD indicate that an RNAP-II having only 5 heptapeptide repeats can bind a gene promoter but is defective in initiating transcription [24]. This mutant CTD is structurally similar to our 1/3 PsiCTD, because it contains the linker region, a very small part of the central region, and the terminal acidic region. Thus, the central region of both the PsiCTD and CTD plays a role in the transition from an initiating polymerase, which generates abortive RNAs, to an elongating enzyme, which produces full- length mRNAs.
###end p 46
###begin p 47
###xml 282 291 278 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g004">Figure 4A</xref>
###xml 504 513 498 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g005">Figure 5A</xref>
###xml 654 658 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Lustig1">[25]</xref>
###xml 1037 1047 1029 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 1147 1151 1139 1143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Saunders1">[26]</xref>
###xml 1322 1326 1314 1318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Smith2">[27]</xref>
###xml 1037 1047 <span type="species:ncbi:7227">Drosophila</span>
An unexpected and interesting observation was made when an RNAP-II with 1/3 PsiCTD was expressed in cells along with wild-type levels of endogenous RNAP-II. Within 16 hours of 1/3 PsiCTD expression, cells ceased to move, changed their shape, formed large aggregates, and soon died (Figure 4A). These dramatic phenotypic changes were not observed when 1/3 PsiCTD was expressed in cells along with very low levels of endogenous RNAP-II. In this case cells merely stopped dividing by day 2 and slowly died (Figure 5A). This differential response may indicate that a wild-type RNAP-II, is required to synthesize protein-coding RNAs used in a stress response [25]. A stress response may account for the observed, abrupt morphological alterations in the cells expressing both the mutant and the endogenous polymerase. An actively transcribing polymerase in cells with abundant wild-type RNAP-II enables cells to respond to the stress imposed by the mutant PsiCTD. In contrast, cells with limited number of active polymerase could not. Indeed, Drosophila stress responses require transcription of heat shock proteins within minutes of the initial stress [26]. This rapid response is accompanied by the release of RNAP-II from its transcriptionally paused state on heat shock genes and depends on transcription elongation factors [27]. If a mechanism similar to this type of elongation control exists in trypanosomes, it raises the intriguing possibility of RNAP-II transcriptional control, heretofore unrecognized, in these organisms.
###end p 47
###begin title 48
Materials and Methods
###end title 48
###begin title 49
Plasmid constructs
###end title 49
###begin p 50
###xml 90 93 90 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 100 103 100 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xho</italic>
###xml 111 115 111 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Wickstead1">[28]</xref>
###xml 245 248 245 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 278 287 278 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 387 391 387 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Wirtz1">[29]</xref>
###xml 278 287 <span type="species:ncbi:5691">T. brucei</span>
The RNAi construct was made in p2T7-177 by inserting a 260 bp region of the RPB1 3'UTR at BamHI and XhoI sites [28]. This plasmid integrates in the highly repressed 177 bp satellite region of a mini-chromosome. The construct was linearized with NotI, transfected into procyclic T. brucei cells and transgenic clonal cell lines selected by limiting dilution in the presence of phleomycin [29].
###end p 50
###begin p 51
###xml 189 192 189 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
pAD71, designed to express a transgene constitutively, was derived from pUC19 and contains sequences for homologous recombination into the procyclin/GPEET locus, following linearization by NotI digestion. The transgene uses the endogenous procyclin/GPEET promoter and a 3'UTR derived from the aldolase mRNA. A blasticidin-resistance gene, which follows the transgene, is co-expressed using actin 5' SAS and 3'UTR regions. pAD74 was derived from pLEW100, minus the luciferase open reading frame and containing a blasticidin-resistance gene in place of the phleomycin-resistance gene and an rRNA promoter in place of the procyclin/GPEET promoter.
###end p 51
###begin p 52
###xml 411 415 409 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Bastin1">[30]</xref>
###xml 746 750 744 748 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Chapman3">[24]</xref>
###xml 807 816 805 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0006959-g001">Figure 1A</xref>
Plasmid RPB3-SBP was generated by joining the RPB3 open reading frame (Tb927.3.550) with the protein A open reading frame and the Streptavidin binding protein (SBP) open reading frame (a gift from Larry Simpson) and cloned into pAD71 downstream from the procyclin/GPEET 5'UTR. To establish mutant RNAP-II, we generated epitope tagged versions of RPB1, with varying truncations of PsiCTD. A Ty1-tag (EVHTNQDPLD) [30] at the N-terminus allowed us to monitor the expression of mutant RPB1 proteins. Transgenes expressing mutant RNAP-II were designed with a well-characterized 3'UTR of aldolase (ALD) mRNA and thus resistant to the RNAi-targeting of endogenous RPB1 mRNA. The C-terminal five conserved amino acids, which contribute to RPB1 stability [24], was included in each of the four transgene constructs (Figure 1A). For constitutive expression of the transgenes, the tagged and mutant RPB1 ORFs were cloned into pAD71. For inducible expression of the transgenes, they were cloned into pAD74. All plasmid constructs were confirmed by DNA sequencing.
###end p 52
###begin title 53
Culturing and transfection of parasites
###end title 53
###begin p 54
###xml 41 50 41 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Wirtz1">[29]</xref>
###xml 391 395 391 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Wirtz1">[29]</xref>
###xml 737 738 729 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 779 781 767 769 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 41 50 <span type="species:ncbi:5691">T. brucei</span>
Procyclic (tsetse midgut form) wild-type T. brucei Lister 427 was grown in SDM-79 supplemented with 10% FCS as described [29]. For all transgene experiments, cells were selected and grown in medium containing tetracycline-free serum. The 29-13 cell line contains the T7 RNAP and the tetracycline repressor that are maintained by their co-expression with G418 and hygromycin-resistance genes [29]. p2T7-177 derivatives were transfected into 29-13 and stable cell lines were selected using 2.5 microg/ml phleomycin. pAD71 and pAD74 derivatives were transfected into 29-13 and selected using 10 microg/ml blasticidin. Inducible RNAi and transgene expression were regulated by addition of 500 ng/ml tetracycline. For metabolic labeling, 5x108cells were incubated with 500 microCi of 32P-orthophosphate (9000 Ci/mmole) in 5 mls of phosphate-free DMEM (40 min, 26degreesC).
###end p 54
###begin title 55
###xml 15 24 <span type="species:ncbi:5691">T. brucei</span>
Preparation of T. brucei nuclear extracts and protein purification
###end title 55
###begin p 56
###xml 75 79 75 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Das2">[31]</xref>
###xml 423 427 423 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Das2">[31]</xref>
###xml 514 516 514 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 204 207 <span type="species:ncbi:12227?0.9375|species:ncbi:11084?0.0390625">TEV</span>
Nuclear extracts were made from the RPB3-SBP cells as previously described [31]. Protein was purified using tandem affinity chromatography; IgG-bound protein was washed and released from the matrix using TEV-protease. Eluted protein was bound to Streptavidin-agarose, washed and eluted with 2 mM biotin-containing buffer. For velocity sedimentation, nuclear extracts were loaded onto a 10-30% sucrose gradient as described [31]. Fractions were collected from the bottom of the tube and analyzed by immunoblotting. 32P-containing RPB1 was in-gel digested with endoproteinase Lys-C (Roche) as recommended by the manufacturer.
###end p 56
###begin title 57
Antibodies and western analyses
###end title 57
###begin p 58
###xml 337 341 333 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Bastin1">[30]</xref>
###xml 654 655 650 651 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 45 52 <span type="species:ncbi:9986">rabbits</span>
###xml 375 382 <span type="species:ncbi:9986">rabbits</span>
Polyclonal anti-PsiCTD antibody, produced in rabbits, recognizes endogenous RPB1 as well as the full-length, 2/3, and 1/3 PsiCTD RPB1 derived from transgenes. All four transgene-derived tagged-RPB1 proteins are also detected with monoclonal anti-Ty1 antibody, generated in the Gull laboratory and kindly provided by the Cross laboratory [30]. Anti-RPB4 antibody, produced in rabbits from recombinant protein as antigen, was used for immunoprecipitation experiments. For immunoprecipitations, nuclear extracts were incubated with anti-RPB4 antibody bound to protein A-sepharose, washed in buffer (20 mM Hepes [pH 7.9], 150 mM KCL, 150 sucrose, 2.5 mM MgCl2, 1 mM EDTA, 2.5 mM DTT, 0.1%NP-40, 1 microM each of pepstatin A, leupeptin, and PMSF) and analyzed by immunoblotting using ECLtrade mark kit from Amersham.
###end p 58
###begin title 59
RNA analysis
###end title 59
###begin p 60
###xml 210 214 197 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Sambrook1">[32]</xref>
###xml 307 309 294 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 424 426 411 413 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 552 554 539 541 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">32</sup>
###xml 560 564 547 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Ullu1">[33]</xref>
###xml 682 686 669 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Bangs1">[34]</xref>
###xml 737 744 <span type="species:ncbi:4097">Tobacco</span>
Total cellular RNA from wild-type and transgenic cells was prepared using Trizoltrade mark reagents. For Northern analysis, 5 microg of total RNA was separated on a formaldehyde-1.2% agarose gel in MOPS buffer [32]. RNA was fragmented by alkali-treatment, transferred to nylon membranes and hybridized with 32P-labelled oligonucleotides. Steady-state SL and U2 RNA levels were determined by primer extension analysis, using 32P-labeled oligonucleotides complementary to these RNAs. Nascent RNA was synthesized in lysolecithin-permeabilized cells using 32P-UTP [33] and profiled on 7M urea 10% polyacrylamide gel. Short transcripts were extracted from the gel, purified according to [34] and resolved on a 7M urea 25% polyacrylamide gel. Tobacco acid pyrophosphatase (Epicentre) and T4 RNA ligase (New England Biolabs) were used according to manufactures' protocols. Data were captured on a Typhoon PhosphorImagertrade mark and quantification was performed using ImageQuanttrade mark software.
###end p 60
###begin title 61
Microscopy
###end title 61
###begin p 62
An Olympus BX61 microscope with Nomarski DIC optics was used to visualize live cells.
###end p 62
###begin title 63
Protein alignments
###end title 63
###begin p 64
###xml 24 33 24 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">T. brucei</italic>
###xml 133 137 133 137 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0006959-Thompson1">[35]</xref>
###xml 139 146 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s2">Results</xref>
###xml 24 33 <span type="species:ncbi:5691">T. brucei</span>
###xml 35 40 <span type="species:ncbi:9606">human</span>
###xml 68 92 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Alignments of RPB1 from T. brucei, human (P24928; Nc_000017.9), and Saccharomyces cerevisiae (YDL140C) were performed using CLUSTALW [35]. Results were manually altered to optimize comparisons and were represented using GeneDoc ().
###end p 64
###begin title 65
Supporting Information
###end title 65
###begin p 66
###xml 77 86 <span type="species:ncbi:5691">T. brucei</span>
Expression of RPB1 proteins with either 1/3 psiCTD or delta- psiCTD inhibits T. brucei cellular growth. (A) Growth curves of transgenic cell lines constitutively expressing a tagged full-length psiCTD (black square), 2/3 psiCTD (gray square), 1/3 psiCTD (grey circle) and delta psiCTD (black circle) RPB1. (B) Western analysis of whole cell lysates demonstrates expression of tagged RPB1s. Phosphorylated and non-phosphorylated forms of RPB1 are present. Anti-psiCTD antibody (top panel) detects the tagged version of the full psiCTD and 2/3 psiCTD, along with endogenous RPB1. Anti-tag (Ty1) BB2 antibody (bottom panel) detects only tagged-RPB1. Whereas the phosphorylated and non-phosphorylated forms of full psiCTD or 2/3 psiCTD are visible, only the non-phosphorylated forms of 1/3 psiCTD or delta- psiCTD are detected.
###end p 66
###begin p 67
(0.39 MB PDF)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin p 69
###xml 130 137 <span type="species:ncbi:15957">Timothy</span>
We thank David Lukac and Karl Drlica for critical reading of the manuscript. We gratefully appreciate the figure illustrations by Timothy Linteau.
###end p 69
###begin title 70
References
###end title 70
###begin article-title 71
Structure of eukaryotic RNA polymerases.
###end article-title 71
###begin article-title 72
Extensive homology among the largest subunits of eukaryotic and prokaryotic RNA polymerases.
###end article-title 72
###begin article-title 73
A unique structure at the carboxyl terminus of the largest subunit of eukaryotic RNA polymerase II.
###end article-title 73
###begin article-title 74
Cracking the RNA polymerase II CTD code.
###end article-title 74
###begin article-title 75
The CTD code.
###end article-title 75
###begin article-title 76
Phosphorylation and functions of the RNA polymerase II CTD.
###end article-title 76
###begin article-title 77
Investigating RNA polymerase II carboxyl-terminal domain (CTD) phosphorylation.
###end article-title 77
###begin article-title 78
Elongation by RNA polymerase II: the short and long of it.
###end article-title 78
###begin article-title 79
A structural perspective of CTD function.
###end article-title 79
###begin article-title 80
Amitochondriate amoebae and the evolution of DNA-dependent RNA polymerase II.
###end article-title 80
###begin article-title 81
Analyses of RNA Polymerase II genes from free-living protists: phylogeny, long branch attraction, and the eukaryotic big bang.
###end article-title 81
###begin article-title 82
Structural basis of core promoter recognition in a primitive eukaryote.
###end article-title 82
###begin article-title 83
Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs.
###end article-title 83
###begin article-title 84
Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms.
###end article-title 84
###begin article-title 85
In trypanosomes the homolog of the largest subunit of RNA Polymerase II Is encoded by two genes and has a highly unusual C-terminal domain structure.
###end article-title 85
###begin article-title 86
###xml 43 61 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Characterization of the RNA polymerases of Trypanosoma brucei: trypanosomal mRNAs are composed of transcripts derived from both RNA polymerase II and III.
###end article-title 86
###begin article-title 87
###xml 0 24 <span type="species:ncbi:372075">Leptomonas costaricensis</span>
Leptomonas costaricensis sp. n. (Kinetoplastea: Trypanosomatidae), a member of the novel phylogenetic group of insect trypanosomatids closely related to the genus Leishmania.
###end article-title 87
###begin article-title 88
###xml 131 149 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Genomic rearrangements and transcriptional analysis of the spliced leader-associated retrotransposon in RNA interference-deficient Trypanosoma brucei.
###end article-title 88
###begin article-title 89
###xml 68 84 <span type="species:ncbi:5664">Leishmania major</span>
Histone acetylations mark origins of polycistronic transcription in Leishmania major.
###end article-title 89
###begin article-title 90
###xml 0 18 0 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 0 18 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Trypanosoma brucei RNA Polymerase II Is Phosphorylated in the Absence of Carboxyl-Terminal Domain Heptapeptide Repeats.
###end article-title 90
###begin article-title 91
###xml 32 50 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Biochemical characterization of Trypanosoma brucei RNA polymerase II.
###end article-title 91
###begin article-title 92
###xml 50 68 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Characterization of RNA polymerase II subunits of Trypanosoma brucei.
###end article-title 92
###begin article-title 93
The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability.
###end article-title 93
###begin article-title 94
Role of the mammalian RNA polymerase II C-terminal domain (CTD) nonconsensus repeats in CTD stability and cell proliferation.
###end article-title 94
###begin article-title 95
###xml 66 84 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Spliced-leader RNA silencing: a novel stress-induced mechanism in Trypanosoma brucei.
###end article-title 95
###begin article-title 96
Breaking barriers to transcription elongation.
###end article-title 96
###begin article-title 97
Regulation of the transcriptional activity of poised RNA polymerase II by the elongation factor ELL.
###end article-title 97
###begin article-title 98
###xml 107 125 <span type="species:ncbi:5691">Trypanosoma brucei</span>
Targeting of a tetracycline-inducible expression system to the transcriptionally silent minichromosomes of Trypanosoma brucei.
###end article-title 98
###begin article-title 99
###xml 114 132 114 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 114 132 <span type="species:ncbi:5691">Trypanosoma brucei</span>
A tightly regulated inducible expression system for conditional gene knock-outs and dominant-negative genetics in Trypanosoma brucei.
###end article-title 99
###begin article-title 100
###xml 82 100 82 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Trypanosoma brucei</italic>
###xml 82 100 <span type="species:ncbi:5691">Trypanosoma brucei</span>
A novel epitope tag system to study protein targeting and organelle biogenesis in Trypanosoma brucei.
###end article-title 100
###begin article-title 101
Trypanosomal TBP functions with the multisubunit transcription factor tSNAP to direct Spliced leader RNA gene expression.
###end article-title 101
###begin article-title 102
Molecular Cloning.
###end article-title 102
###begin article-title 103
Permeable trypanosome cells as a model system for transcription and trans-splicing.
###end article-title 103
###begin article-title 104
Mass spectrometry of mRNA cap 4 from trypanosomatids reveals two novel nucleosides.
###end article-title 104
###begin article-title 105
CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice.
###end article-title 105
###begin p 106
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 106
###begin p 107
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This work was supported by National Institutes of Health-NIAID grant AI535835 and AI29478 to VB and by a Scientist Development Award (0735532T) from the American Heart Association to AD. NIH URL is ; AHA URL is . The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 107

